Data and Sample Use Policy
The OMRF Autoimmune Disease Institute provides samples, de-identified clinical data, and experimental data to investigators with the understanding that all institutional policies regarding human subject research (IRB approvals) will be appropriately followed. Material transfer agreements (MTA) are to be executed PRIOR to shipping/sending any samples or data outside of the institution. When the Core provides samples to individuals within OMRF, all requests will require documentation of an IRB approved study. When the Core provides samples to individuals outside of OMRF, all requests will require documentation of an IRB approved study, FWA # of approving IRB, and documentation of execution of a MTA before samples or data will be provided.
The OMRF Autoimmune Disease Institute Clinical, Biorepository, Phenotyping, Bioinformatics, and Serum Analyte and Biomarker Cores are subsidized by multiple NIH and other non-profit funding sources. As per NIH regulations, all funding sources associated with Autoimmune Disease Institute Core services must be cited in presentations and publications resulting from the use of core services.
Investigators who receive data, samples, or analysis support implicitly agree to cite the Cores in all publications and presentations where these materials are used. Investigators must also provide the publication drafts to the Cores prior to submission to ensure that all appropriate funding sources and collection contributors are acknowledged. Additionally, all investigators receiving Core services will guarantee that all reasonable efforts will be undertaken to ensure appropriate PMCID entry is completed in a timely and accurate fashion.
The funding sources to be acknowledged when Core services are utilized include: P30GM103510, P20RR020143, and P30AR0763750. Each manuscript resulting from data, samples, or analysis support produced from usage of Core services requires the following verbiage per the NIH:
Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases and from the National Institute of General Medical Sciences of the National Institutes of Health under award numbers P30GM103510, P20RR020143, and P30AR0763750. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.